Citations

Showing 10 of 108162 citations.

Faculty Opinions recommendation of Preliminary findings and outcomes associated with the use of a continuous spinal protocol for labor pain relief following accidental dural puncture.
Sviggum, Hans P.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | October 22, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.736647990.793566188 Get It

Communicating uncertainties when disclosing diagnostic test results for (Alzheimer's) dementia in the memory clinic: The ABIDE project
Visser, Leonie N.C. , Pelt, Sophie, Kunneman, Marleen , Claus, Jules J. , Kalisvaart, Kees J. , Hempenius, Liesbeth, Beer, Marlijn H. de, Roks, Gerwin , Boelaarts, Leo, Kleijer, Mariska, Smets, Ellen M.A. , Hillen, Marij A. , Bouwman, Femke H. , Flier, Wiesje M. van der

Mayo Clinic

Health Expectations | October 22, 2019 | Volume: 23 | Issue: 1 | Pages: 52-62

10.1111/hex.12964 | PMID 31638322 Get It

AbstractBackgroundThe development of novel diagnostics enables increasingly earlier diagnosis of Alzheimer's disease (AD). Timely diagnosis may benefit patients by reducing their uncertainty regarding the cause of symptoms, yet does not always provide patients with the desired certainty.ObjectiveTo examine, using both quantitative and qualitative methods, uncertainty communicated by memory clinic clinicians in post‐diagnostic testing consultations with patients and their caregivers.MethodsFirst, we identified all uncertainty expressions of 22 clinicians in audiotaped post‐diagnostic testing consultations with 78 patients. Second, we statistically explored relationships between patient/clinician characteristics and uncertainty expressions. Third, the transcribed uncertainty expressions were qualitatively analysed, determining the topic to which they pertained, their source and initiator/elicitor (clinicians/patients/caregivers).ResultsWithin 57/78 (73%) consultations, clinicians expressed in total 115 uncertainties, of which 37% elicited by the patient or caregiver. No apparent relationships were found between patient/clinician characteristics and whether or not, and how often clinicians expressed uncertainty. Uncertainty expressions pertained to ten different topics, most frequently patient's diagnosis and symptom progression. Expressed uncertainty was mostly related to the unpredictability of the future and limits to available knowledge.Discussion and conclusionsThe majority of clinicians openly discussed the limits of scientific knowledge and diagnostic testing with patients and caregivers in the dementia context. Noticeably, clinicians did not discuss uncertainty in about one quarter of consultations. More evidence is needed on the beneficial and/or harmful effects on patients of discussing uncertainty with them. This knowledge can be used to support clinicians to optimally convey uncertainty and facilitate patients' uncertainty management.
Comparison of Gene Delivery to the Kidney by Adenovirus, Adeno-Associated Virus, and Lentiviral Vectors After Intravenous and Direct Kidney Injections
Rubin, Jeffrey D. , Nguyen, Tien V., Allen, Kari L. , Ayasoufi, Katayoun , Barry, Michael A. , Barry, Michael A , Ayasoufi, Katayoun , Nguyen, Tien V.

Mayo Clinic

Human Gene Therapy | October 22, 2019 | Volume: 30 | Issue: 12 | Pages: 1559-1571

10.1089/hum.2019.127 | PMID 31637925 Get It

There are many kidney diseases that might be addressed by gene therapy. However, gene delivery to kidney cells is inefficient. This is due, in part, to the fact that the kidney excludes molecules above 50 kDa and that most gene delivery vectors are megaDaltons in mass. We compared the ability of adeno-associated virus (AAV), adenovirus (Ad), and lentiviral (LV) vectors to deliver genes to renal cells. When vectors were delivered by the intravenous (IV) route in mice, weak luciferase activity was observed in the kidney with substantially more in the liver. When gene delivery was observed in the kidney, expression was primarily in the glomerulus. To avoid these limitations, vectors were injected directly into the kidney by retrograde ureteral (RU) and subcapsular (SC) injections in mice. Small AAV vectors transduced the kidney, but also leaked from the organ and mediated higher levels of transduction in off-target tissues. Comparison of AAV2, 6.2, 8, and rh10 vectors by direct kidney injection demonstrated highest delivery by AAV6.2 and 8. Larger Ad and LV vectors transduced kidney cells and mediated less off-target tissue transduction. These data demonstrate the utility of direct kidney injections to circumvent the kidney size exclusion barrier. They also identify the effects of vector size on on-target and off-target transduction. This lays the foundation for the use of different vector platforms for gene therapy of diverse kidney diseases.
Nursing’s public image in the Republic of Georgia: A qualitative, exploratory study
Squires, Allison , Ojemeni, Melissa T. , Olson, Emma, Uchanieshvili, Maia, Uchaneishvili, Maia

Mayo Clinic

Nursing Inquiry | October 22, 2019 | Volume: 26 | Issue: 4 | Pages: No page available

10.1111/nin.12295 | PMID 31637805 Get It

AbstractThe public image of nursing is important because it can facilitate or create barriers to achieving an adequate supply of nursing human resources. This study sought to gain a better understanding of nursing’s professional image within the Republic of Georgia. The Nursing Human Resources Systems model was used to guide the study’s exploratory, qualitative approach. Data collection occurred over a 2‐week period in the Republic of Georgia, and thirty‐three participants formed the final study sample. Participants included healthcare professionals, key informants from nonprofit and research institutions, and patients. Data analysis occurred using directed content analysis techniques, and three themes emerged: (a) gender dimension; (b) the nursing service recipient experience; and (c) historical legacies. Themes revealed the complexities of nursing’s image in the country. Findings from this study serve as baseline data for understanding nursing’s image in the Republic of Georgia which could assist with improving pre‐entry nursing production issues.
Practical algorithms for amyloid β probability in subjective or mild cognitive impairment
Maserejian, Nancy N., Bian, Shijia , Jaeger, Judith , Syrjanen, Jeremy A. , Aakre, Jeremiah A. , Jack, Clifford R. , Aakre, Jeremiah, Jack, Clifford R , Wang, Wenting , Mielke, Michelle M. , Gao, Feng

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | October 21, 2019 | Volume: 11 | Issue: 1 | Pages: 710-720

10.1016/j.dadm.2019.09.001 | PMID 31700988 Get It

AbstractIntroductionPractical algorithms predicting the probability of amyloid pathology among patients with subjective cognitive decline or mild cognitive impairment may help clinical decisions regarding confirmatory biomarker testing for Alzheimer's disease.MethodsAlgorithm feature selection was conducted with Alzheimer's Disease Neuroimaging Initiative and Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing data. Probability algorithms were developed in Alzheimer's Disease Neuroimaging Initiative using nested cross‐validation accompanied by stratified subsampling to obtain 1000 internally validated decision trees. Semi‐independent validation was conducted using Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Independent external validation was conducted in the population‐based Mayo Clinic Study of Aging.ResultsTwo algorithms were developed using age and normalized immediate recall z‐scores, with or without apolipoprotein E ε4 carrier status. Both algorithms had robust performance across data sets and when substituting different recall memory tests.DiscussionThe statistical framework resulted in robust probability estimation. Application of these algorithms may assist in clinical decision‐making for further testing to diagnose amyloid pathology.
Explaining Obesity- and Smoking-related Healthcare Costs through Unconditional Quantile Regression
Naessens, James M. , Olsen, Kerry D., Shah, Nilay D., Naessens, James , Olsen, Kerry, Shah, Nilay , Borah, Bijan J.

Mayo Clinic

Journal of Health Economics and Outcomes Research | October 21, 2019 | Volume: 1 | Issue: 1 | Pages: 23-41

10.36469/9849 | PMID 37664147 Get It

Background: This paper assesses obesity- and smoking-related incremental healthcare costs for the employees and dependents of a large U.S. employer. Objectives: Unlike previous studies, this study evaluates the distributional effects of obesity and smoking on healthcare cost distribution using a recently developed econometric framework: the unconditional quantile regression (UQR). Methods: Results were compared with the traditional conditional quantile regression (CQR), and the generalized linear modeling (GLM) framework that is commonly used for modeling healthcare cost. Results: The study found strong evidence of association of healthcare costs with obesity and smoking. More importantly, the study found that these effects are substantially higher in the upper quantiles of the healthcare cost distribution than in the lower quantiles. The insights on the heterogeneity of impacts of obesity and smoking on healthcare costs would not have been captured by traditional mean-based approaches. The study also found that UQR impact estimates were substantially different from CQR impact estimates in the upper quantiles of the cost distribution. Conclusions: These results suggest the potential role that smoking cessation and weight management programs can play in arresting the growth in healthcare costs. Specifically, given the finding that obesity and smoking have markedly higher impacts on high-cost patients, such programs appear to have significant cost saving potential if targeted toward high-cost patients.
Multicentric reticulohistiocytosis: the Mayo Clinic experience (1980–2017)
Sánchez-Álvarez, Catalina , Sandhu, Avneek Singh, Crowson, Cynthia S. , Wetter, David A. , McKenzie, Gavin , Lehman, Julia S. , McKenzie, Gavin A , Makol, Ashima , Lehman, Julia S , Sanchez-Alvarez, Catalina

Mayo Clinic

Rheumatology | October 21, 2019 | Volume: 59 | Issue: 8 | Pages: 1898-1905

10.1093/rheumatology/kez555 | PMID 31742640 Get It

Abstract Objectives Multicentric reticulohistiocytosis (MRH), a rare histiocytic disease that can mimic other rheumatic conditions, may be associated with cancer and other autoimmune disorders. To better understand the disorder and its other associations, we aimed to evaluate clinical correlates and outcomes of all patients with MRH seen at Mayo Clinic, Rochester between 1980 and 2017. Methods A retrospective medical record review was conducted to identify all patients with MRH between 1 January 1980 and 30 April 2017. Results We identified 24 patients with biopsy-proven MRH (58% female, 75% Caucasian, median age at diagnosis 52 years, median follow-up of 2.3 years). All patients had cutaneous and articular involvement; 23 (96%) patients had papulonodular skin lesions (87% periungual and dorsal hand) and seven (30%) mucosal nodules; and 22 (92%) patients had arthralgias, 21 (88%) joint effusions and 13 (54%) synovitis. Most frequently used therapies included corticosteroids, cyclophosphamide, methotrexate and bisphosphonates. Biologics were used in four patients. Nine patients had symptomatic resolution at 1 year and 12 partial improvement. Radiological findings included erosive changes in three (60%) patients and arthritis mutilans in two patients (40%). Twenty-nine per cent of patients had a concomitant autoimmune disease and 25% malignancy including melanoma, endometrial, peritoneal and lung carcinoma. The 5-year survival rate was 85% (95% CI: 74, 100%). Conclusion To our knowledge, this is the largest single-centre series of patients with MRH highlighting the rarity of the condition and an unmet need for treatment options that can allow sustained disease remission. It also highlights the need for a high vigilance for malignancy and autoimmune diseases.
Clinical Progress Note: Addressing Prognosis in Advanced Dementia
Ansari, Aziz , Pomerantz, Daniel, Abedini, Nauzley C. , Jayes, Robert L., Matti‐Orozco, Brenda, Havyer, Rachel D.

Mayo Clinic

Journal of Hospital Medicine | October 21, 2019 | Volume: 15 | Issue: 11 | Pages: 678-680

10.12788/jhm.3316 | PMID 31634101 Get It

Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Gökbuget, Nicola , Kantarjian, Hagop M. , Brüggemann, Monika , Stein, Anthony S. , Bargou, Ralf C. , Dombret, Hervé , Heffner, Leonard T., Rigal‐Huguet, Françoise , Litzow, Mark R. , Gao, Shan , Nagorsen, Dirk , Forman, Stephen J. , Topp, Max S. , Kantarjian, Hagop , Fielding, Adele K. , O’Brien, Susan , Zugmaier, Gerhard

Mayo Clinic

Blood Advances | October 21, 2019 | Volume: 3 | Issue: 20 | Pages: 3033-3037

10.1182/bloodadvances.2019000457 | PMID 31648325 Get It

Key Points MRD response has value as a prognostic factor for blinatumomab treatment in R/R B-cell precursor ALL. MRD response was associated with better outcomes in terms of OS and RFS in blinatumomab-treated R/R ALL.